多项细胞因子对子宫内膜异位症的诊断价值被引量：1

导出

摘要子宫内膜异位症（EMS）是常见的妇科疾病，多见于育龄女性，发生率呈逐年上升趋势。目前EMS的诊断主要依靠症状、体征及妇科检查、B超检查，确诊则需手术病理，但手术有创伤性。本文旨在研究血清白细胞介素6（IL-6）、白细胞介素8（IL-8）、肿瘤坏死因子仪（TNF—d）、C-反应蛋白（CRP）、癌相关糖链抗原125（CA125）和癌相关糖链抗原19—9（CA19—9）水平对EMS的诊断价值。

作者韩雪玲

机构地区天津医科大学总医院天津市中心妇产科医院

出处《浙江临床医学》 2011年第12期1402-1404,共3页 Zhejiang Clinical Medical Journal

关键词子宫内膜异位症诊断价值细胞因子血清白细胞介素相关糖链抗原肿瘤坏死因子 C-反应蛋白妇科疾病

分类号 R711.71 [医药卫生—妇产科学]

引文网络
相关文献

参考文献12

1王志萍,蔡呈香.血清CA_(125)检测在妇科疾病临床应用的评价(附208例病例报告)[J].海峡药学,2005,17(1):61-64. 被引量：3
2陈羽,朱士杰.血清CA125测定及超声检查诊断子宫腺肌病的临床分析[J].浙江临床医学,2006,8(11):1184-1184. 被引量：2
3李琼珊.血清EMAb和CA125联合测定在诊断Ⅰ期、Ⅱ期子宫内膜异位症中的价值[J].浙江临床医学,2005,7(7):712-712. 被引量：2
4I shigami S,Natsugo e S,Ho kita S,et al.Clinical importance of preopretive careinoembryonie antigen and carbohydrate antigen 199 levels in gastric cancer.J Clin Gastro,2001,32(1):41-44.
5Mann DV,Edwards R,Ho S,et al.Elevated tumor marker CA199:Clinica l interpretation and influence of obstructive jaundice.Eur J Surg Ocol,2000,26:474-479.
6Slater M,Cooper M,Murphy CR.Human grow th hormone and interleukin-6 up regulated in endometriosis and endometriod adencarcinoma.Acta Histochem,2006,108(1):3203-3210.
7Janelle L,Yasemin S,Umit AK,et al.Regulation of interleukin-8 expression in human endometrial endothelial cells:a protein mechanism for the pathogenesis of endometriosis.Obstet tics and Gyneco lo gy,2005,90(3):1805-1811.
8Sabatine MS,Morrow DA,Jablonski KA,et al.Prognostic siguificance of the centers for disease control american heart association high -sensitivity C-reactive protein cul points for cardiovascular and other oueomes in patients with stable coronary artery disease.Circulation,2007,115(12):1528-1536.
9Komulainen P,Lakka TA,Kivipelto M,et al.Serum high sensitivity C-reactive protein and cognitive function in elderly women.Ageing,2007,36(4):443-448.
10DHooghe TM,Mihalyi AM,Simsa P,et al.Whywe need a noninvasive diagnostic test for minimal to mild endometriosis with a high sensitivity.Gynecol Obstetinvesl,2006,62:136-138.

二级参考文献12

1伍俊萍,张惜阴.子宫内膜异位症患者血清CA_（125）、抗子宫内膜抗体的测定[J].中华妇产科杂志,1996,31(9):562-562. 被引量：27
2de Brui jn HWA, van der Zee AGJ, Aalders JG. The value of cancer antigen 125 (CA125)during treatment and follow-up of patients with ovarian cancer [J]. Curr Opin Obstet Gynecol 1997;9:8～13.
3Hoshiai H, Ishikawa M, Sawatari Y, et al. Laparoscopic evaluation of the onset and progression of endometriosis[J]. Am J Obstet Gynecol,1993,169:714.
4Masahashi T, Matsuzawa K, Ohsawa M, Narita O, Asai T,Ishihara M. Serum CA 125 levels in patients with endometriosis:changes in CA125 levels during menstruation[J]. Obstet Gynecol 1988;72:328～331.
5Mol BWJ, Bayram N, Lijmer JG, Wiegerinck MAHM, Bongers MY, van der Veen F, et al. The performance of CA125measurement in tbe detection of endometriosis;a meta-analysis[j].Fert Steril 1998;70:1101～1108.
6何茜冬.子宫腺肌症228例的临床分析[EB/OL].现代医院网络版,.
7张翠媛张雪芳.子宫内膜异位症的诊治新进展.医学理论与实践网络版,2001,01:34-34.
8Use of CA125in clinical Trial Evaluation of New Therapeutic Drugs for Ovarian Cancer[J]. Clin. Cancer Res. , June 1, 2004;10(11) :3919～3926.
9周卫昌,郭卫学.超声医学.北京:科学技术文献出版社,2000.1116.
10Krasnicki D.Serum and Peritoneal fluid CA125 concentration in women with endometriosis.Ginekol Dol,2001,72(12A):1365.